|
A Study of Two Anti-HIV Drug Combinations Clinical Trials Information presented on Clinical Trials Search is not intended to be a substitute for qualified health advice, trips or treatment by using a genuine doctor. We aren't doctors. Always consult your mD on A Study of Two Anti-HIV Drug Combinations conditions. Clinical Trials Search.org is a site committed to listing clinical research studies in human subjects. A Study of Two Anti-HIV Drug Combinations Clinical research trials and A Study of Two Anti-HIV Drug Combinations health trials take place in a lot of of cities across the US. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally measure the potency of new drugs. The aim of the studies / projects is to answer specific human medical questions. Clinical trials are a popular manner for physicians, government agencies, and private sector corporations to discover remedies for all kinds of circumstances, like A Study of Two Anti-HIV Drug Combinations. A Study of Two Anti-HIV Drug Combinations Clinical Trials and other clinical trials allow for volunteers to have health treatment alternatives before they are available to the general public. Many times the test subjects obtain treatment for without cost, and occasionally they are paid for their time. Sometimes there is a cost for a A Study of Two Anti-HIV Drug Combinations clinical trial. Subjects oftentimes recieve the most effective healthcare possible for their A Study of Two Anti-HIV Drug Combinations condition. Hazards are a reality, however, and could include additional or frequent doctor visits, healthcare dangers (perhaps life-threatening), and/or the treatment being ineffective. Trials are federally governed with exacting guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "A" Clinical Trials Conditions > A Study of Two Anti-HIV Drug Combinations  A Study of Two Anti-HIV Drug Combinations
A Study of Two Anti-HIV Drug Combinations
For Condition: HIV Infections
Status: Completed
Sponsor(s): Glaxo Wellcome ,
Synopsis: The purpose of this study is to compare the safety and effectiveness of taking lamivudine (3TC) plus zidovudine (ZDV) plus a protease inhibitor (PI) with taking the 3TC/ZDV combination tablet (Combivir) plus a PI. This study also examines how well patients follow the dosing schedules for these drugs. Doctors believe that taking Combivir plus a PI may be as effective as taking 3TC plus ZDV plus a PI.
Details: It is hypothesized that a fixed-dose 3TC/ZDV tablet given bid in combination with a protease inhibitor is clinically equivalent in its effect on plasma HIV-1 RNA level to a conventional regimen of 3TC, ZDV, and a protease inhibitor. Patients are stratified according to their current protease inhibitor therapy and randomized to receive open-label therapy of 1 Combivir tablet bid (Arm II) or an equivalent dose of 3TC and ZDV (Arm I), plus their current protease inhibitor for 16 weeks.
Eligibility:
Study Type: Interventional, Treatment, Parallel Assignment, Safety Study
Minimum Age/Maximum Age: 18 Years/
Genders: Both
Protocol Entry Criteria: Inclusion Criteria Patients must have: - HIV infection documented by a licensed antibody ELISA assay and confirmed by Western blot, positive HIV blood culture, positive HIV serum antigen, or plasma viremia. - CD4+ cell count of at least 300 cells/mm3. - HIV-1 RNA less than 10,000 copies/ml by Roche Amplicor PCR assay. - CDC Category A or B Classification for HIV infection (no clinical diagnosis of AIDS). - Compliance with dosing schedule and protocol evaluations. Prior Medication: Required: - 3TC at 150 mg bid, ZDV at 600 mg/day (200 mg tid or 300 mg bid), plus a marketed protease inhibitor (ritonavir, saquinavir, indinavir, or nelfinavir) at its recommended dose for at least 10 weeks. Allowed: - Inhaled corticosteroids for the treatment of asthma. Exclusion Criteria Co-existing Condition: Patients with the following conditions or symptoms are excluded: - Malabsorption syndromes affecting drug absorption (e.g., Crohn's disease and chronic pancreatitis). - Enrollment in other investigational protocols. Concurrent Medication: Excluded: - Cytotoxic chemotherapeutic agents. - Nonnucleoside reverse transcriptase inhibitors. - Other investigational agents. Concurrent Treatment: Excluded: Radiation therapy. Prior Medication: Excluded: - Cytotoxic chemotherapeutic and immunomodulating agents such as systemic corticosteroids, IF-2, alpha-IFN, beta-IFN, or gamma-IFN (except for inhaled corticosteroids for the treatment of asthma) within 4 weeks of study entry. - HIV immunotherapeutic vaccine within 3 months of study entry. Prior Treatment: Excluded: Radiation therapy within 4 weeks of study entry.
Total Enrollment:
Location and Contact Information:
San Juan AIDS Program
Santurce, , 00907
Puerto Rico
Univ of Wisconsin School of Medicine
Madison, Wisconsin, 53792
United States
Pacific Oaks Med Ctr
Beverly Hills, California, 90211
United States
Tower Infectious Diseases / Med Associates Inc
Los Angeles, California, 90048
United States
Carolinas Med Ctr
Charlotte, North Carolina, 28232
United States
Infectious Diseases Physicians Inc
Annandale, Virginia, 22003
United States
Univ of North Carolina Hosps
Chapel Hill, North Carolina, 27599
United States
Additional Information:
Study ID Numbers: 280A; NZTA4001
Study Start Date:
Record last reviewed: November 1998
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00002203
Other Hiv Infections Studies:
1. A Study of Ritonavir (an Anti-HIV Drug) in HIV-Positive Infants and Children
2. A Study of 1592U89 and Ethanol When Given Together to HIV-Infected Patients
3. Effectiveness of Anti-HIV Drugs in Patients Who Have Not Received Previous Anti-HIV Drugs During Different Stages of HIV Infection
4. Open, Non-comparative Study of Fluconazole in Patients With Coccidioidal Meningitis
5. A Study of Cytotoxic T Lymphocyte (CTL) Therapy in HIV-Infected Patients
Related Studies:
Other HIV Infections Clinical Trials
Other Wisconsin Clinical Trials
Other Madison Clinical Trials
A Study of Two Anti-HIV Drug Combinations
|
|
|
|
|
|
|
|
